Cancer Research

Israeli tech entrepreneur Maor Shlomo, who sold Base44 to Wix for $80 million, launched the Second Light fund to invest in cancer research. Shlomo discusses how artificial intelligence is transforming medical discovery, the challenges of biological validation, and the future of healthcare.